Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours
- PMID: 577471
- PMCID: PMC2025523
- DOI: 10.1038/bjc.1977.123
Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours
Abstract
Administration of ovine prolactin alone supported growth of hormone-dependent GR mouse mammary tumours. Growth of hormone-independent tumours was not stimulated. Furthermore, administration of bromocriptine, a compound that inhibits release of prolactin from the pituitary gland, was shown to inhibit the growth of hormone-dependent tumours in animals receiving treatment with progesterone + oestrone. Administration of prolactin or bromocriptine to mice bearing tumours that grew independently of progesterone + oestrone treatment had no influence on tumour growth. We conclude that direct as well as indirect evidence has been found for the involvement of prolactin in the growth of transplanted, hormone-dependent GR mouse mammary tumours.
Similar articles
-
Sex hormone receptors in mammary tumours of GR mice.Nature. 1976 Sep 30;263(5576):386-9. doi: 10.1038/263386a0. Nature. 1976. PMID: 987544
-
Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.Int J Cancer. 1979 Jul 15;24(1):92-6. doi: 10.1002/ijc.2910240116. Int J Cancer. 1979. PMID: 478693
-
Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.Cancer Lett. 1985 Sep 15;28(2):237-41. doi: 10.1016/0304-3835(85)90080-1. Cancer Lett. 1985. PMID: 4052994
-
Ergolines as potential prolactin and mammary tumor inhibitors.Lloydia. 1977 Jan-Feb;40(1):90-106. Lloydia. 1977. PMID: 327183 Review. No abstract available.
-
[Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man].Vopr Onkol. 1976;22(12):81-91. Vopr Onkol. 1976. PMID: 798416 Review. Russian.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources